Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-02-19

FDA Approved: TADALAFIL — Supplemental Application (Alembic Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for tadalafil from Alembic Pharmaceuticals Inc., enabling a generic tadalafil product. The approval covers the same indi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TADALAFIL (TADALAFIL)

Snippet

SUPPL AP for TADALAFIL (TADALAFIL)